NCT01412060 A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia Status COMPLETED Phase PHASE3
NCT01411085 Risperidone and Desipramine in Alcohol Use and Schizophrenia Status COMPLETED Phase PHASE2
NCT01410357 Improving Outcomes for Individuals With Serious Mental Illness and Diabetes Status COMPLETED Phase NA
NCT01409590 Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications Status COMPLETED Phase NA
NCT01401491 Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine Status COMPLETED Phase PHASE4
NCT01399450 Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients Status COMPLETED Phase PHASE4
NCT01399437 Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia Status COMPLETED Phase N/A
NCT01397786 Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Status COMPLETED Phase PHASE3
NCT01394601 A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia Status COMPLETED Phase N/A
NCT01394471 Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia Status COMPLETED Phase PHASE1
NCT01392482 IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder Status COMPLETED Phase N/A
NCT01391403 Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia Status COMPLETED Phase PHASE3
NCT01389908 A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder Status UNKNOWN Phase NA
NCT01387542 Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants Status COMPLETED Phase PHASE4
NCT01384604 Neurophysiological Studies in Schizophrenia and Psychiatric Disorders Status COMPLETED Phase N/A